https://doi.org/10.1074/mcp.ra118.001304
T
Thomas Kryza
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
1.1K
Citations
19
h-index
29
i10-index
Thomas Kryza is an academic researcher from Advantest (Singapore). The author has contributed to research in topics: Coagulation, Bradykinin, Polyphosphates, and Angioedema & Prostate Cancer Treatment and Research & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 19, co-authored 59 publications.
ORCID: 0000-0003-1668-8551Papers by this author
worksIntegration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome
2019 · Molecular & Cellular Proteomics · 30 citations
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
2024 · British Journal of Cancer · 11 citations
https://doi.org/10.1038/s41416-024-02584-z
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
2024 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-024-52472-6
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
2025 · Clinical Cancer Research · 3 citations
https://doi.org/10.1158/1078-0432.ccr-24-2865
Biochemical activity induced by a germline variation in KLK3 (PSA) associates with cellular function and clinical outcome in prostate cancer
2023 · Research Square · 1 citations
https://doi.org/10.21203/rs.3.rs-2650312/v1
Etude de l'implication de la kallicréine 12 dans le remodelage tissulaire associé aux pathologies pulmonaires
2013 · theses.fr (ABES) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat